Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-02-25 @ 10:04 PM
Study NCT ID:
NCT03979651
Status:
COMPLETED
Last Update Posted:
2025-05-22
First Post:
2019-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma
Sponsor:
Hospices Civils de Lyon
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
69HCL19_0115
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None